Treatment of airway obstruction by metallic stents in infants and children  by Vinograd, Itzhak et al.
General Thoracic Surgery Vinograd et al
G
TSTreatment of airway obstruction by metallic stents in
infants and children
Itzhak Vinograd, MD,a Sergei Keidar,a Marc Weinberg,a and Aviel SilbigerbFrom the Departments of Pediatric Sur-
gerya and Anesthesiology,b Dana Chil-
dren’s Hospital, Tel-Aviv Sourasky Medi-
cal Center and Sackler Faculty of Medicine,
Tel-Aviv University, Tel-Aviv, Israel.
Received for publication Dec 8, 2003; re-
visions received Aug 25, 2004; accepted for
publication Oct 12, 2004.
Address for reprints: Itzhak Vinograd, MD,
Department of Pediatric Surgery, Dana
Children’s Hospital Sourasky Medical Cen-
ter, Tel-Aviv, Israel (E-mail: vinopesu@
tasmc.health.gov.il).
J Thorac Cardiovasc Surg 2005;130:146-50
0022-5223/$30.00
Copyright © 2005 by The American Asso-
ciation for Thoracic Surgery
Dr Vinograddoi:10.1016/j.jtcvs.2004.10.011
146 The Journal of Thoracic and CardioObjective: The internal metallic stent is a relatively new and controversial method
for the treatment of airway collapse in infants and children. The study examined the
outcomes of this treatment in a large group of patients and defined clear indications
for airway stenting.
Methods: A retrospective review was conducted of 32 patients in whom 42 stents
were inserted. The patients were divided into three groups with respect to the stented
segment: group A, trachea (n  14); group B, bronchi (n  16); and group C,
trachea and bronchi (n  2).
Results: In 30 cases, there was immediate improvement of respiratory obstruction,
and 23 patients could be weaned, at least temporarily, from ventilation. Excessive
granulation developed after the stenting in 26 patients. In 6 patients, all in group A,
the granulation and inflammatory reaction generated severe airway obstruction,
necessitating thoracotomy in 2 cases. One patient died of airway obstruction, and
another died during the attempt to remove the stent; both were in group A. Stents
placed for 2 to 72 months (mean 8.7 months) have now been removed in 11 patients.
Six children are alive and well with stents in place, 2 from group A and 4 from group
B. Fifteen patients died during the follow-up period; in 13 cases, death was related
to the associated disease.
Conclusion: The use of metallic stents, especially in the trachea, is associated with
a high rate of complications. Granulation tissue, which often develops after stenting,
is a major concern. Removal of the stents is arduous and carries a high risk of
complications. The use of stents should be restricted to the limited situations in
which conventional initial therapy has failed.
Airway obstruction in infants and children is a challenging problem. Manysurgical techniques have been suggested to stabilize the narrowed airwaylumen, although none of them is universally accepted. The concept of stent
implantation for airway obstruction was first introduced by Filler and colleagues1,2
in 1992, then later by others in much smaller groups of patients, with balloon-
expandable metallic stents,3-6 shape memory stents,7,8 or self-expanding endobron-
chial stents.9 The preliminary results seemed promising; however, through the years
there were increasing numbers of reports of technical difficulties and complications
related to stent implantation,10,11 and the use of internal airway stents became
controversial. The purposes of this study were to assess the outcome of this
treatment in a relatively large group of patients and to define clear indications for
airway stenting.
Materials and Methods
A retrospective review was conducted of all patients who had undergone airway stenting
since 1995. Forty-two stents were inserted in 32 infants and children aged 1 to 64 months
(mean 4.5 months). According to the site of stent implantation, the patients were divided into
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TSthree groups (Table 1): group A (n  14), trachea; group B (n 
16), major bronchi; and group C (n  2), trachea and bronchi. In
7 patients in group A, 3 in group B, and 2 in group C, more than
one stent was needed to maintain a stable, open airway. Stents
were placed by rigid bronchoscopy with the patients under general
anesthesia. The exact site for stenting was determined by the
simultaneous use of endoscopy and fluoroscopy. Some adjustment
of the stent’s position at the completion of the procedure was
possible by gentle traction with grasping forceps.
Two different stents were used in all three groups. NiTi-ITS, a
shape memory stent made of nitinol, an alloy with “shape memory
effect” (type I)12 was used in 4 patients, all in group A. A Palmaz
37 stent (type II; Johnson & Johnson International Systems Co,
Warren, NJ) was used in 28 patients. We used the medium size
Palmaz stents P-154 and P-204 with diameter of 3 mm and lengths
of 14.7 mm and 19.6, mm respectively, and expanded diameters of
4 to 9 mm. The most frequent indication for stenting was inability
to extubate: 10 infants in group A, 11 in group B, and infants in
group C. The mean period of ventilation before the stent placement
was 12 weeks (range 8-16 weeks). One patient underwent segmen-
tal resection, and 2 underwent tracheal autografts, all in group A.
Among the other 29 patients, airway obstruction was associated
with malacia in 7 and extrinsic compression by a major vessel or
hypertrophic heart in 22.
Severe cardiac disease was a frequent associated problem and
was present in 10 infants in group A, 13 in group B, and in 2
TABLE 1. Clinical data
Group
A
Group
B
Group
C Total
Cases 14 16 2 32
Type of stent
NiTi-ITS 4 — —
Palmaz P-154 9 21 4
Palmaz P-204 3
No. of stents 16 22 4 42
Age at stenting (mo, mean) 8.1 3.1 2.2
Associated cardiac disease
Transposition of the great arteries 1 3 — 4
Complete atrioventricular canal 2 6 2 10
Hypoplastic left heart syndrome 1 4 — 5
Cardiomyopathy 3 — — 3
Vascular ring 3 — — 3
Other associated disease
Trisomy 18 3 6 — 9
VATER 6 1 — 7
Severe failure to thrive 10 15 2 27
Other 6 3 — 9
Indication
Inability to extubate 10 11 2 23
Recurrent cyanotic spells 4 5 — 9
Recurrent pneumonia 2 6 1 9
All data represent numbers of patients unless otherwise specified. VATER,
Vertebral defects, imperforate anus, tracheoesophageal fistula, and radial
and renal dysplasia.infants in group C. Other cardiac malformations included transpo-
The Journal of Thoracisition of the 2 great arteries (3 patients), hypoplastic left heart
syndrome (5 patients), vascular ring (3 patients), and cardiomyop-
athy (3 infants) in group A. In all three groups, 25 patients had an
additional major disease; 21 had more than one associated disease
(Table 1). There were 8 infants each with complete atrioventricular
canal in groups B and C and 2 in group A.
Stent removal was performed in the operating room through a
rigid bronchoscope under fluoroscopic control with general anes-
thesia. A scrub nurse with an open thoracotomy set was present in
the room. Extracorporeal membrane oxygenation or a bypass ma-
chine were not used for backup. Toothed grasping forceps were
used to hold the upper end of the stent. The handle of the forceps
was rotated to decrease the diameter of the stent and allow it to
break loose from the tracheal wall. Usually, significant force had to
be applied to detach the stent from the airway mucosa. The stent
was then brought into the lumen of the bronchoscope, and the
bronchoscope with the stent inside was withdrawn from the air-
way. Once the stent was removed, little bleeding was noted; such
bleeding stopped spontaneously in all cases.
In this study, there were no clearly defined guidelines for stent
removal. When the stent was well tolerated, it was left in place for
at least 6 to 8 months. Stents were removed whenever airway
obstruction occurred, or when the major cardiovascular disease
was overcome, respiratory symptoms had resolved, and the airway
proximal and distal to the stented segment appeared stable on
bronchoscopy.
The families were advised of the novel nature of this method of
treatment. Informed consent outlining possible complications, in-
cluding the obscure long-term results, was obtained in all cases.
Results
There were no complications related to stent insertion, and
stent placement was well tolerated by all patients (Table 2).
TABLE 2. Clinical results of airway stenting
Group
A
Group
B
Group
C Total
Immediate relief of airway obstruction 13 15 2 30
Stenting failure 1 1 2
Weaned from mechanical ventilation 10 11 2 23
Stent in place (mo, mean) 11.2 14.1 4.1
Complications
Granulation 9 10 1 20
Airway obstruction 6 — — 6
Stent migration 2 1 — 2
Tracheoesophageal fistula 1 — — 1
Death* 2 — — 2
No. of stents removed 7 4 — 11
Last follow-up
Alive and well with stent removed 7 4 — 11
Alive and well with stent in place 2 4 — 6
Dead* 7 6 4 15
All data represent numbers of patients unless otherwise specified. *In 13
cases, death was not related to airway stenting, but to the associated
disease.Immediate relief of airway obstruction was achieved in 30
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cation for stent insertion was inability to wean from venti-
lation, 21 could be weaned from mechanical ventilation
within 24 to 48 hours after the airway stenting. In 2 infants,
1 each in groups A and B, the airway stenting failed to
improve airway obstruction. One infant in group A with
severe subglottic stenosis eventually required tracheostomy
after the tracheal stenting. The second patient (group B), a
3-year-old infant with complete atrioventricular canal and
hypoplastic right ventricle, had severe, isolated, long-seg-
ment left main bronchomalacia. Repeated attempts to re-
lieve the obstruction with two internal stents failed. Almost
complete atelectasis of the left lung subsequently
developed.
Excessive granulation formation was the prominent com-
plication of airway stenting. The upper ends of the stents in
groups B and C and the lower ends of the stents in group A
were the sites of the most exuberant granulation. Excessive
granulation tissue developed in all 4 patients with type I
(nitinol) stents, protruding into the lumen of the trachea
between the metallic spiral arms of the stents.
In only 6 patients had the stent epithelialized well by 20
to 60 days. At follow-up bronchoscopy in those patients, the
stents had become almost fully covered by respiratory mu-
cosa, without any evidence of granulation. In 20 patients, 9
in group A and 10 in group B, the inflammatory reaction did
not result in significant airway obstruction or infection, but
those patients did require repeated bronchoscopy. The gran-
ulation tissue was removed by scraping it with the sharp
edges of the rigid bronchoscope suction and sometimes by
use of bronchoscopic grasping forceps. In 6 patients, all
from group A, the granulation and inflammatory reaction
generated severe airway obstruction. In only 2 of those
patients could the extreme respiratory distress be relieved
by bronchoscopic manipulation; in the other 4, the stents
had to be removed. In 2 of those 4, the stents could not be
removed through the bronchoscope, and emergency divi-
sion of the trachea through a midsternotomy was performed.
In a 3-month-old infant who had undergone segmental
tracheal resection for congenital stenosis, the stent could not
be removed even after opening the trachea, and the patient
died during the attempt to remove the stent. In another
infant in group A with a type I stent, excessive granulation
produced severe airway obstruction. The infant died in
another hospital before any attempt was made to relieve the
obstruction. This might possibly have been avoided had
bronchoscopy and immediate removal of the stent, or even
tracheostomy, been attempted at presentation.
In 2 patients in group A and 1 in group B, there was mild
stent migration, which necessitated repositioning of the
stent in 1 case and stent removal in the other 2. Eleven stents
were removed from 10 children. In group A, the stents
remained in place between 4 and 72 months (mean 11.2
148 The Journal of Thoracic and Cardiovascular Surgery ● Julymonths); in group B, they remained between 11.2 and 40.2
months (mean 14.1 months); and in group C, they remained
between 2.2 and 8.2 months (mean 4.1 months). After the
stents were removed, a small amount of mucosal bleeding
was usually encountered; this stopped spontaneously within
minutes. Considerable care was necessary in manipulating
the stent and keeping the airway clear of blood after re-
moval. Once the stent was successfully removed, however,
no complications appeared in any of our patients.
Removal of the stent was more difficult in group A
patients with excessive granulation and in those in whom
the stent was embedded into the airway mucosa. There was
no correlation between complications and the length of time
the stents were in situ.
In 1 patient, a recurrent tracheoesophageal fistula devel-
oped 4 years after the original repair and 1 year after the
tracheal stenting. The stent was removed, and the fistula was
subsequently successfully repaired. Before the original re-
pair through the right fourth intercostals space, the fistula
was identified with bronchoscopy, and a Fogarty 2F catheter
was inserted through it into the esophagus. This was helpful
in locating the fistula, which was than divided, and each side
was closed with fine sutures. A pleural intercostal muscle
flap was placed between the tracheal and esophageal fistula
closures.
As of the most recent follow-up, there are 11 children
alive and well whose stents were removed, 4 from group A
and 7 from group B. Six patients are alive and well with
stents in place, 2 from group A and 4 from group B. Fifteen
patients died during the follow-up period; in 13 cases, death
was related to the associated diseases (7 from group A, 4
from group B, and 2 from group C).
Seven patients died free of airway problems; the other 4
still had persistent mild airway problems, none of them
necessitating reintubation. Two patients in group B under-
went tracheostomy to relieve upper airway obstruction.
Discussion
The treatment of serious airway obstruction caused by tra-
cheobronchomalacia, intractable airway stenosis, or airway
compression by other organs is, even today, a forbidding
challenge. To date, many therapeutic approaches have been
suggested, none of which has been widely adopted for
pediatric patients.3 The various surgical techniques of
patching, resecting, suspending, or external stenting of the
malacic airway segment have not been widely embraced.
On the other hand, implantation of an endoluminal stent that
will give rigid support to the malacic segment and thereby
prevent inspiratory collapse seems to be a logical and prac-
tical option. Silicone elastomer and absorbable stents cur-
rently used in adult patients have external diameters that
preclude their use in children. Other stents, such as stainless
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doned because of technical problems.13
Nowadays it is generally accepted that the technique of
stent insertion is straightforward. The endoscopic equip-
ment is available in most pediatric surgical units, and most
of the different types of stent are readily obtainable. In most
cases, the respiratory relief is dramatic and gratifying.
In this study, 23 patients were able to be extubated
shortly after airway stenting. Some were tube dependent for
a few months. There were no complications related to stent
insertion in any of the patients. However, there are still
several very significant, unresolved problems associated
with the metallic stents that make their use questionable and
controversial. Although the length of the stent can be accu-
rately determined at bronchoscopy, it is our experience that
the decision regarding the appropriate expanded diameter of
the stent is much more difficult. A balloon that is too small
will not expand the stent to reach the wall of the airway and
will lead to stent displacement. A balloon diameter that is
too large may overexpand the stent and apply excessive
pressure on the wall of the airway, leading to ischemia or an
aggressive inflammatory reaction. In this study, the self-
expanding titanium alloy stent resulted in excessive granu-
lation in all 4 patients, and although extraction of the stent
was easy, its use was abandoned until the implantation
method could be revised.
Because one is inserting foreign material into the airway,
it would be ideal to remove a stent after it was no longer
needed. Although we were able to remove the stent in 11
cases, the danger of the removal must be reemphasized, and
removal of internal stents, particularly in patients in group
A, can be a very serious, even life-threatening, procedure.
As noted, 1 infant in this series died during the attempt to
remove the stent, and another required tracheostomy after
tracheal division. All possible measures must be on hand to
relieve life-threatening airway obstruction that may occur
during stent removal. Stents that are completely covered by
airway mucosa, or those with excessive granulation, specif-
ically in group A, carry a greater risk of complications
during attempted removal. Once an attempt is being made to
remove the stent, it is very difficult to abandon the proce-
dure. At that point, if airway obstruction occurs and the
stent cannot be removed, possible access to the trachea
would be through the neck or immediate midsternotomy.
Other measures, such as extracorporeal membrane oxygen-
ation or cardiopulmonary bypass, as suggested by others,14
do not seem to be applicable in these cases. It is possible,
however, that, in group B patients, one-lung intubation
might allow enough time to apply one of those procedures.
The question of the optimal period of airway stenting is
unclear. In symptom-free patients, especially if there is
concern about the safety of the patient during stent removal,
a rational approach would be to leave it in place and
The Journal of Thoraciundertake periodic dilatations. The long-term effect of
stenting on airway growth is another concern. To date, no
problems have been noted, but the number of children
studied is small,2 and the longest times a stent was in place
in this study were 6 years in 1 patient in group A and 4 years
in 2 patients in group B.
The most prominent and distressing problem encoun-
tered was the tendency of the Palmaz stent to cause
obstructing granulation tissue over the stent. This re-
sulted in severe airway obstruction in 6 children, all in
group A, and necessitated emergency stent removal. An-
other 20 patients required repeated bronchoscopies to
clear the granulation tissue. Granulation was more com-
mon in patients in group A (n  15) than in groups B and
C (n  11). In only 6 patients in this study was the stent
well covered by respiratory mucosa without any evidence
of granulation. There is no obvious explanation for the
excessive granulation formation with metallic stents.
Some have suggested that it is related to preoperative
tracheal inflammation, whereas others1 believe that the
excessive granulation is due to overexpansion of the
stent. There are limited data in the pediatric population to
support the latter contention; in our study we could not
find any clear correlation between airway overexpansion
and excessive granulation. Tracheal inflammation was
not regarded as a contraindication to stent placement in
this study.
Other problems occurring after stent insertion are in-
frequent, although they can be severe or even fatal. In
this series, 3 children with stent migration and 1 with
recurrent tracheoesophageal fistula were treated success-
fully by repositioning of the stent in 1 case and removal
of the stents in 3. Cook and associates11 have reported a
fatal complication of aortobronchial fistula in a 14-year-
old boy. Others have reported complications associated
with stents, including dysphagia and severe hemoptysis.
In an effort to decrease these complications, various
types of stent are currently undergoing investigation. The
ideal pediatric airway stent remains elusive, and each
stent type has its own advantages and disadvantages.14
Stent use in the treatment of pediatric airway obstruction
should be restricted to the limited situations in which
conventional initial therapy has failed. Our results with
the implantation of the currently available airway metal-
lic stents indicate that although it is an effective method
of treatment, it is associated with a high complication
rate, particularly in the case of tracheal stenting. The
nitinol (type I) stent was associated with severe problems
of airway obstruction, and although the stent can easily
be extracted, its use was suspended pending further im-
provement in its design.
Extraction of the stent is difficult and dangerous, and
the long-term results are still unclear. Until better stents
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critically ill with stenosis or compression that cannot be
resolved safely with current surgical procedures.
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